Recent patterns in minimally invasive colectomies: Where are we now?

被引:0
|
作者
Laredo, Jonathan A. [1 ]
Patel, Devanshi [1 ]
Byerly, Saskya [1 ]
Filiberto, Dina M. [1 ]
Wood, Elizabeth H. [1 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Surg, Memphis, TN 38152 USA
来源
LAPAROSCOPIC ENDOSCOPIC AND ROBOTIC SURGERY | 2025年 / 8卷 / 01期
关键词
Robotic surgery; Laparoscopy; Colectomy; LAPAROSCOPIC SURGERY; ROBOTIC SURGERY; COLON-CANCER; FUNDAMENTALS; SURVIVAL; OUTCOMES; TRENDS;
D O I
10.1016/j.lers.2024.09.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Minimally invasive surgery (MIS) techniques such as laparoscopy and robotic surgery for colorectal resection have been cited as superior to traditional open surgery because of their associations with decreased operating room time, hospital stay length, and postoperative morbidity. Despite these benefits, the open approach remains a common surgical method for colorectal resection procedures. We aim to evaluate the most recent yearly trends in open, laparoscopic, and robotic approaches to provide insight into uptake and present the status of MIS in the field of colorectal surgery. Methods: Data were collected from the American College of Surgeons National Surgical Quality Improvement Program targeted colectomy database for the years 2014-2020. The surgical approach was classified as either open, laparoscopic, or robotic. Analysis was performed to identify trends in colorectal surgery categorized by year, patient age, American Society of Anesthesiologists (ASA) classification, body mass index (BMI), and emergency status. Results: There was an overall decline in both open and laparoscopic surgery cases (from 38.4% to 34.4% and from 57.4% to 50.8%, respectively) and an overall increase in robotic surgery cases (from 4.2% to 14.8%) from 2014 through 2020. Open surgery was the most common approach for the lowest BMI category (<18.5 kg/m2), highest risk ASA classes (4-5) and most emergent surgeries, whereas robotic surgery rates were negligible for these groups. Laparoscopy was the most prevalent approach for all other categories. Conclusion: Laparoscopy was the most prevalent approach in colorectal surgery, although the total case proportions generally tended to decrease. While open surgery remains the approach of choice for emergent procedures, laparoscopic case proportions increased marginally in this category, likely owing to increases in surgeon comfort and continued expansion of laparoscopic training efforts. Importantly, the total prevalence of robotic surgery increased significantly between 2014 and 2020, which may be attributable to advancements in the robotic platform and increases in familiarity and competence with the technology. We anticipate a continuation of these trends in the future and recommend the creation of a national robotic surgery training standard. (c) 2024 Zhejiang University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:23 / 27
页数:5
相关论文
共 50 条
  • [31] Recent advances and new challenges in minimally invasive surgery and chemotherapy for colorectal cancer
    Hashida, Hiroki
    FRONTIERS IN SURGERY, 2024, 10
  • [32] Prognostic scores in advanced heart failure: where are we now and where are we going?
    Nessler, Jadwiga
    Rostoff, Pawel
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (04): : 235 - 237
  • [33] CAR-T cell therapy: Where are we now, and where are we heading?
    Wang, Jia-Yi
    Wang, Liang
    BLOOD SCIENCE, 2023, 5 (04): : 237 - 248
  • [34] Oncoplastic breast surgery: where are we now
    De Lorenzi, Francesca
    Alessandri-Bonetti, Mario
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2025, 34 (01) : 53 - 55
  • [35] Predicting outcome in melanoma: where are we now?
    Jennings, L.
    Murphy, G. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (03) : 496 - 503
  • [36] Therapy outcome measures: Where are we now?
    John, Alexandra
    INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2011, 13 (01) : 36 - 42
  • [37] Neoadjuvant Therapy in Melanoma: Where Are We Now?
    Saad, Mariam
    Tarhini, Ahmad A.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (04) : 325 - 339
  • [38] The role of technology in minimally invasive surgery: state of the art, recent developments and future directions
    Tonutti, Michele
    Elson, Daniel S.
    Yang, Guang-Zhong
    Darzi, Ara W.
    Sodergren, Mikael H.
    POSTGRADUATE MEDICAL JOURNAL, 2017, 93 (1097) : 159 - 167
  • [39] Colorectal Cancer Biomarkers: Where Are We Now?
    Gonzalez-Pons, Maria
    Cruz-Correa, Marcia
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [40] Metformin and Breast Cancer: Where Are We Now?
    Cejuela, Monica
    Martin-Castillo, Begona
    Menendez, Javier A.
    Pernas, Sonia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)